• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可切除胃癌未行手术治疗:对政策变化和区域化的影响

Failure to operate on resectable gastric cancer: implications for policy changes and regionalization.

作者信息

Frohman Heather A, Martin Jeremiah T, Le Anh-Thu, Dineen Sean P, Tzeng Ching-Wei D

机构信息

Department of Surgery, University of Kentucky Medical Center, Lexington, Kentucky.

Department of Cardiothoracic Surgery, Southern Ohio Medical Center, Portsmouth, Ohio.

出版信息

J Surg Res. 2017 Jun 15;214:229-239. doi: 10.1016/j.jss.2017.03.043. Epub 2017 Mar 31.

DOI:10.1016/j.jss.2017.03.043
PMID:28624049
Abstract

BACKGROUND

A significant proportion of patients never receive curative-intent surgery for resectable gastric cancer (GC). The primary aims of this study were to identify disparities and targetable risk factors associated with failure to operate in the context of national trends in surgical rates for resectable GC.

METHODS

The National Cancer Database was used to identify patients with resectable GC (adenocarcinoma, clinical stage IA-IIIC, 2004-2013). Multivariate modeling was used to identify predictors of resection and to analyze the impact of surgery on overall survival (OS).

RESULTS

Of 46,970 patients with resectable GC, 18,085 (39%) did not receive an appropriate operation. Among unresected patients, 69% had no comorbidities. Failure to resect was associated with reduced median OS (44.4 versus 11.8 mo, hazard ratio [HR]: 2.09, P < 0.001). In the multivariate analysis, the most critical factors affecting OS were resection (HR: 2.09) and stage (reference IA; HR range: 1.16-3.50, stage IB-IIIC). Variables independently associated with no surgery included insurance other than private or Medicare (odds ratio [OR]: 1.60/1.54), nonacademic/nonresearch hospital (OR: 1.16), non-Asian race (OR: 1.72), male (OR: 1.19), older age (OR: 1.04), Charlson-Deyo score >1 (OR: 1.17), residing in areas with median income <$48,000 (OR: 1.23), small urban populations <20,000 (OR: 1.41), and stage (reference IA; OR range: 1.36-3.79, stage IB-IIIC, P < 0.001).

CONCLUSIONS

Over one-third of patients with resectable GC fail to receive surgery. Suitable insurance coverage and treatment facility are the most salient (and only modifiable) risk factors for omitting surgery. To mitigate national disparities in surgical care, policymakers should consider improving insurance coverage in underserved areas and regionalization of gastric cancer care.

摘要

背景

相当一部分可切除胃癌(GC)患者从未接受过根治性手术。本研究的主要目的是在可切除GC手术率的国家趋势背景下,确定与未进行手术相关的差异和可靶向的风险因素。

方法

利用国家癌症数据库确定可切除GC患者(腺癌,临床分期IA-IIIC,2004 - 2013年)。采用多变量建模来确定切除的预测因素,并分析手术对总生存期(OS)的影响。

结果

在46970例可切除GC患者中,18085例(39%)未接受适当手术。在未接受手术的患者中,69%没有合并症。未进行切除与中位OS降低相关(44.4个月对11.8个月,风险比[HR]:2.09,P < 0.001)。在多变量分析中,影响OS的最关键因素是切除(HR:2.09)和分期(参照IA期;HR范围:1.16 - 3.50,IB-IIIC期)。与未进行手术独立相关的变量包括非私人或医疗保险以外的保险(优势比[OR]:1.60/1.54)、非学术/非研究医院(OR:1.16)、非亚裔种族(OR:1.72)、男性(OR:1.19)、年龄较大(OR:1.04)、Charlson-Deyo评分>1(OR:1.17)、居住在收入中位数<$48,000的地区(OR:1.23)、城市人口少<20,000(OR:1.41)以及分期(参照IA期;OR范围:1.36 - 3.79,IB-IIIC期,P < 0.001)。

结论

超过三分之一的可切除GC患者未接受手术。合适的保险覆盖范围和治疗机构是未进行手术最显著(且唯一可改变)的风险因素。为减轻手术治疗方面的国家差异,政策制定者应考虑改善服务不足地区的保险覆盖范围以及胃癌治疗的区域化。

相似文献

1
Failure to operate on resectable gastric cancer: implications for policy changes and regionalization.可切除胃癌未行手术治疗:对政策变化和区域化的影响
J Surg Res. 2017 Jun 15;214:229-239. doi: 10.1016/j.jss.2017.03.043. Epub 2017 Mar 31.
2
Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.术前放化疗联合胃切除术治疗的可切除胃癌患者生存的预测因素
J Am Coll Surg. 2015 Jul;221(1):83-90. doi: 10.1016/j.jamcollsurg.2015.04.004. Epub 2015 Apr 15.
3
Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.术后并发症对胃癌根治性切除术后的复发和生存无影响。
Eur J Surg Oncol. 2016 Jan;42(1):132-9. doi: 10.1016/j.ejso.2015.08.163. Epub 2015 Sep 3.
4
Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.医院间差异及术后并发症对可切除胃癌围手术期化疗(放化疗)应用的影响。荷兰上消化道癌症审计研究结果。
Eur J Surg Oncol. 2018 Apr;44(4):532-538. doi: 10.1016/j.ejso.2018.01.008. Epub 2018 Jan 12.
5
Long term follow up and retrospective study on 533 gastric cancer cases.533例胃癌病例的长期随访及回顾性研究
BMC Surg. 2014 May 16;14:29. doi: 10.1186/1471-2482-14-29.
6
Adherence with operative standards in the treatment of gastric cancer in the United States.美国胃癌治疗中手术标准的遵循情况。
Gastric Cancer. 2020 May;23(3):550-560. doi: 10.1007/s10120-019-01028-5. Epub 2019 Nov 19.
7
Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.新辅助化疗对可切除胃癌围手术期结局的使用情况及影响趋势:来自美国外科医师学会国家癌症数据库的证据
Surgery. 2016 Apr;159(4):1099-112. doi: 10.1016/j.surg.2015.11.004. Epub 2015 Dec 17.
8
Survival outcomes of geriatric patients with clinically resectable gastric cancer: to operate or not.老年临床可切除胃癌患者的生存结局:是否进行手术
J Surg Res. 2016 Dec;206(2):481-489. doi: 10.1016/j.jss.2016.08.040. Epub 2016 Aug 12.
9
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.治疗前中性粒细胞与淋巴细胞比值可独立预测可切除的胃食管交界部癌和胃腺癌的疾病特异性生存率。
Ann Surg. 2016 Feb;263(2):292-7. doi: 10.1097/SLA.0000000000001189.
10
[Hospital volume effects in surgical treatment of gastric cancer : Results of a prospective multicenter observational study].[医院容量对胃癌手术治疗的影响:一项前瞻性多中心观察性研究的结果]
Chirurg. 2017 Apr;88(4):328-338. doi: 10.1007/s00104-016-0292-0.

引用本文的文献

1
Attrition after Neoadjuvant Chemotherapy in Foregut Cancer: Experience at a Tertiary Center in the Deep South.前肠癌症新辅助化疗后的损耗:美国最南部一家三级中心的经验
Ann Surg Oncol. 2025 Jul 17. doi: 10.1245/s10434-025-17795-8.
2
Patient-Reported Barriers to Foregut Cancer Care in the Deep South.美国最南部地区患者报告的前肠癌症护理障碍
Ann Surg Oncol. 2025 Jun;32(6):3900-3912. doi: 10.1245/s10434-025-17113-2. Epub 2025 Mar 4.
3
Time Kills: Impact of Socioeconomic Deprivation on Timely Access to Guideline-Concordant Treatment in Foregut Cancer.
时间造成的危害:社会经济剥夺对前肠癌症患者及时接受符合指南治疗的影响
J Am Coll Surg. 2024 Apr 1;238(4):720-730. doi: 10.1097/XCS.0000000000000957. Epub 2024 Mar 15.